A ten-year follow-up on stage II Malignant Melanoma patients treated postsurgically with newcastle disease virus oncolysate

A Multifactorial Analysis of Melanoma

1981 • 368 citations

A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle disease virus oncolysate

1983 • 171 citations

Factors Prognostic for Survival in Patients with Malignant Melanoma Spread to the Regional Lymph Nodes

1982 • 163 citations

Newcastle Disease Virus as an Antineoplastic Agent: Induction of Tumor Necrosis Factor- and Augmentation of Its Cytotoxicity2

1988 • 143 citations

PROGNOSIS IN MALIGNANT MELANOMA.

1964 • 128 citations

Malignant Melanoma

1965 • 102 citations

Biostatistical Basis of Elective Node Dissection

1977 • 92 citations

Axillary Dissection in Melanoma

1990 • 91 citations

Prognostic Value of Lymph Node Dissection in Malignant Melanoma

1980 • 74 citations

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

1977 • 63 citations

Viral oncolysate in the management of malignant melanoma.II. Clinical studies

1977 • 54 citations

Viral oncolysate in the management of malignant melanoma.I. Preparation of the oncolysate and measurement of immunologic responses

1977 • 53 citations

Virus‐augmented tumor transplantation antigens: Evidence for a helper antigen mechanism

1974 • 51 citations

CLINICAL STUDIES EMPLOYING INTERFERON INDUCERS IN MAN AND ANIMALS *

1970 • 23 citations

Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate

1986 • 23 citations